Cargando…
The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488509/ https://www.ncbi.nlm.nih.gov/pubmed/23067542 http://dx.doi.org/10.1186/1746-1596-7-142 |
_version_ | 1782248626304581632 |
---|---|
author | Xu, Huan Cao, Dayan Guo, Guoning Ruan, Zhihua Wu, Yuzhang Chen, Yongwen |
author_facet | Xu, Huan Cao, Dayan Guo, Guoning Ruan, Zhihua Wu, Yuzhang Chen, Yongwen |
author_sort | Xu, Huan |
collection | PubMed |
description | OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), have not yet been determined in cases of HBV-related acute-on-chronic liver failure (HBV-ACLF) patients. METHODS: In this study, the expression of BTLA and HVEM in liver tissues from HBV-ACLF, chronic hepatitis B (CHB) patients and healthy individuals was analyzed by immunohistochemistry. RESULTS: The results of this analysis demonstrated that both molecules were observed in the HBV-ACLF samples and that their expression was chiefly in the infiltrating inflammatory cells and the damaged bile ducts. However, they were absent in liver sections from CHB patients and healthy controls. Immunofluorescence double-staining indicated that BTLA was found on CK-18(+) epithelial cells, CD31(+) endothelial cells, CD68(+) macrophages, CD56(+) NK cells, CD16(+) monocytes, CD3(+) , CD8(+) T cells, and Foxp3(+) regulatory T cells (Treg). By contrast, HVEM expression was restricted to CK18(+) epithelial cells and CD68(+) macrophages. Moreover, the expression of several members of the B7 superfamily, including PD-L1, PD-L2, B7-H3 and B7-H4, was also detected in these liver tissues, and these proteins were co-expressed with HVEM. Interestingly, the expression of fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant molecule, was also found in liver sections from HBV-ACLF, this molecule also co-expresses with BTLA and HVEM. CONCLUSIONS: These results suggest that BTLA-HVEM signaling is likely to affect the pathogenesis of HBV-ACLF, a clear understanding of the functional roles of these proteins should further elucidate the disease process. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8080806838149123 |
format | Online Article Text |
id | pubmed-3488509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34885092012-11-05 The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure Xu, Huan Cao, Dayan Guo, Guoning Ruan, Zhihua Wu, Yuzhang Chen, Yongwen Diagn Pathol Research OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), have not yet been determined in cases of HBV-related acute-on-chronic liver failure (HBV-ACLF) patients. METHODS: In this study, the expression of BTLA and HVEM in liver tissues from HBV-ACLF, chronic hepatitis B (CHB) patients and healthy individuals was analyzed by immunohistochemistry. RESULTS: The results of this analysis demonstrated that both molecules were observed in the HBV-ACLF samples and that their expression was chiefly in the infiltrating inflammatory cells and the damaged bile ducts. However, they were absent in liver sections from CHB patients and healthy controls. Immunofluorescence double-staining indicated that BTLA was found on CK-18(+) epithelial cells, CD31(+) endothelial cells, CD68(+) macrophages, CD56(+) NK cells, CD16(+) monocytes, CD3(+) , CD8(+) T cells, and Foxp3(+) regulatory T cells (Treg). By contrast, HVEM expression was restricted to CK18(+) epithelial cells and CD68(+) macrophages. Moreover, the expression of several members of the B7 superfamily, including PD-L1, PD-L2, B7-H3 and B7-H4, was also detected in these liver tissues, and these proteins were co-expressed with HVEM. Interestingly, the expression of fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant molecule, was also found in liver sections from HBV-ACLF, this molecule also co-expresses with BTLA and HVEM. CONCLUSIONS: These results suggest that BTLA-HVEM signaling is likely to affect the pathogenesis of HBV-ACLF, a clear understanding of the functional roles of these proteins should further elucidate the disease process. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8080806838149123 BioMed Central 2012-10-15 /pmc/articles/PMC3488509/ /pubmed/23067542 http://dx.doi.org/10.1186/1746-1596-7-142 Text en Copyright ©2012 Xu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Xu, Huan Cao, Dayan Guo, Guoning Ruan, Zhihua Wu, Yuzhang Chen, Yongwen The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure |
title | The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure |
title_full | The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure |
title_fullStr | The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure |
title_full_unstemmed | The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure |
title_short | The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure |
title_sort | intrahepatic expression and distribution of btla and its ligand hvem in patients with hbv-related acute-on-chronic liver failure |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488509/ https://www.ncbi.nlm.nih.gov/pubmed/23067542 http://dx.doi.org/10.1186/1746-1596-7-142 |
work_keys_str_mv | AT xuhuan theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT caodayan theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT guoguoning theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT ruanzhihua theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT wuyuzhang theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT chenyongwen theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT xuhuan intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT caodayan intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT guoguoning intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT ruanzhihua intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT wuyuzhang intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure AT chenyongwen intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure |